Literature indicates that ARL6IP5 is also associated with angiogenesis, cell proliferation, apoptosis, metastasis, and resistance to chemotherapy in gastric, ovarian, and breast cancer.29 This evidence concerns the gene ARL6IP5 and breast carcinoma.